Literature DB >> 6786808

Effect of probucol on the activity of postheparin plasma lipoprotein lipase and hepatic lipase.

T A Miettinen, J K Huttunen, T Kuusi, T Kumlin, S Mattila, V Naukkarinen, T Strandberg.   

Abstract

The effect of discontinuation of long term (34-56 months) probucol treatment on serum lipids, lipoproteins and on the activity of postheparin plasma lipoprotein and hepatic lipase ahs been studied in 10 healthy males participating in a primary prevention programme of coronary heart disease. A significant increase was observed in the activity of postheparin plasma lipoprotein lipase, in the total serum cholesterol concentration and in the serum concentrations of high density lipoprotein (HDL) cholesterol, HDL phospholipids and apoprotein AI after withdrawal of the drug No changes were seen in the serum triglyceride levels or in the activity of postheparin plasma hepatic lipase. The activity of postheparin plasma hepatic lipase tended to correlate with the serum concentration of HDL. No correlations were present between the individual changes in the serum levels of HDL and in the activity of postheparin plasma triglyceride lipases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786808     DOI: 10.1016/0009-8981(81)90440-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.

Authors:  F Heller; C Harvengt
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 2.  Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

3.  Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.

Authors:  N Tanno; S Oikawa; M Koizumi; H Kotake; H Hirakawa; Y Kanazawa; T Toyota
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

4.  Iatrogenic profound hypoalphalipoproteinaemia: an unrecognised cause of very low HDL cholesterol.

Authors:  M J Murphy; A Duncan; B D Vallance; C J Packard; D S O'Reilly
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.